D Hossfeld

Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group

G.B. Ryan, Giovanni Martinelli, Marion Kuper‐Hommel et al. · Annals of Oncology · 2007 · 249 citations · Full text

Prognostic Factors, Lymphoid Neoplasia, Breast Oncology +4

Long-Term Results of First-Line Sequential High-Dose Etoposide, Ifosfamide, and Cisplatin Chemotherapy Plus Autologous Stem Cell Support for Patients With Advanced Metastatic Germ Cell Cancer: An Extended Phase I/II Study of the German Testicular Cancer Study Group

Hans‐Joachim Schmoll, Christian Kollmannsberger, Bernd Metzner et al. · Journal of Clinical Oncology · 2003 · 160 citations

Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma: results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG)

Andreas Josting, Christian Rudolph, MY Mapara et al. · Annals of Oncology · 2004 · 157 citations · Full text

Lymphoid Neoplasia, Large Multicenter Study, Surgical Oncology +6

Randomized phase III trial comparing infused irinotecan/5-fluorouracil (5-FU)/folinic acid (IF) versus 5-FU/FA (F) in stage III colon cancer patients (pts). (PETACC 3)

Eric Van Cutsem, Roberto Labianca, D Hossfeld et al. · Journal of Clinical Oncology · 2005 · 130 citations

Gastroenterology, Pathology, Adjuvant Chemotherapy +17

Pretreatment serum levels of matrix metalloproteinase-9 and vascular endothelial growth factor in non-small-cell lung cancer

Eckart Laack, Annika Köhler, C. Kugler et al. · Annals of Oncology · 2002 · 95 citations · Full text

Oncology, Non-small-cell Lung Cancer, Medicine +9